Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2012
03/14/2012CN102370626A Floating tablet preparation of yolk immunoglobulin IgY for preventing and treating human gastric diseases
03/14/2012CN101775371B Anti-testicle-protein hTSC29 antibody or antibody fragment and application thereof
03/14/2012CN101732709B Method for preparing haemorrhagic fever vaccine by culturing primary cells in multilayer culture flask
03/14/2012CN101721693B Improved recombinant bacillus calmetter Guerin (BCG)
03/14/2012CN101565455B CTL epitope polypeptides of bird flu H5N1 virus and applications thereof
03/13/2012US8133983 Agonistic binding molecules to the human OX40 receptor
03/13/2012US8133982 FcγRIIB specific antibodies and methods of use thereof
03/13/2012US8133981 Therapeutic use of anti-CS1 antibodies
03/13/2012US8133980 Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof
03/13/2012US8133973 Immunogenic compositions for Chlamydia trachomatis
03/13/2012US8133972 IgE antigenic peptides
03/13/2012US8133877 Composition comprising an antisense sequence implicated in the regulation of angiogenesis
03/13/2012US8133873 Recombinant chemokine-antigen vaccine
03/13/2012US8133866 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
03/13/2012US8133857 NOTCH inhibition in the treatment of atherosclerosis
03/13/2012US8133744 Production of antibodies and to medical uses involving antibodies
03/13/2012US8133728 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012US8133726 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012US8133723 Vaccines against multiple subtypes of influenza virus
03/13/2012US8133720 Biosensor
03/13/2012US8133712 Inactivated chimeric vaccines and related methods of use
03/13/2012US8133681 Chemo-immunotherapy method
03/13/2012US8133666 Method for identifying agents capable of inhibiting APOBEC3C activity in HIV-infected cells
03/13/2012US8133498 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
03/13/2012US8133497 Systems and methods for delivery of a therapeutic agent
03/13/2012US8133496 Compositions and methods for diagnosing and treating urinary tract infections
03/13/2012US8133495 Live attenuated antigenically marked classical swine fever virus
03/13/2012US8133494 Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2
03/13/2012US8133493 Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
03/13/2012US8133492 Pneumococcus polysaccharide-related vaccines
03/13/2012US8133491 Compositions and methods for treatment of hyperplastic disorders
03/13/2012US8133490 Method and system to remove cytokine inhibitors in patients
03/13/2012US8133489 Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof
03/13/2012US8133488 Methods and compositions for targeting polyubiquitin
03/13/2012US8133487 Soluble heterodimeric cytokine receptor
03/13/2012US8133486 Method and composition for altering a B cell mediated pathology
03/13/2012US8133485 Immunoglobulin specifi for mast cell immunoglobulin receptor (IRp60) for use in treatment and prevention of allergic disorders
03/13/2012CA2699834C Improved anti-il-6 receptor antibody
03/13/2012CA2567254C Tc-83-derived alphavirus vectors, particles and methods
03/13/2012CA2540529C Means and methods for the recruitment and identification of stem cells
03/13/2012CA2525615C Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine
03/13/2012CA2505942C West nile virus vaccine
03/13/2012CA2505527C Method for suppressing immune system response to transplanted tissue or cells
03/13/2012CA2489227C Hla-a24-restricted cancer antigen peptides
03/13/2012CA2459811C Modified peptides and their use for the treatment of autoimmune diseases
03/13/2012CA2457015C Method for inducing selectively suppressed immune response
03/13/2012CA2455406C Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
03/13/2012CA2441601C Bacteriophage-mediated immunisation
03/13/2012CA2429120C Salmonella vaccine
03/13/2012CA2423038C Live vaccine and method of manufacture
03/13/2012CA2402191C Use of insulin for the treatment of cartilagenous disorders
03/13/2012CA2365898C Ibd-associated microbial antigens and methods of using same
03/13/2012CA2356779C Cytokine receptor chain
03/13/2012CA2347649C Mn gene and protein
03/13/2012CA2256308C Antibodies to the ed-b domain of fibronectin, their construction and uses
03/13/2012CA2208524C Delivery of nucleic acid molecules to mucosal tissue
03/13/2012CA2195955C Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/12/2012DE20321890U1 Impfstoffzusammensetzung The vaccine composition
03/12/2012DE20321889U1 Impfstoffzusammensetzung The vaccine composition
03/08/2012WO2012031280A2 Identification and enrichment of cell subpopulations
03/08/2012WO2012031273A2 Novel modulators and methods of use
03/08/2012WO2012031271A1 Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines
03/08/2012WO2012031258A1 Recombinant t-cell receptor ligands with covalently bound peptides
03/08/2012WO2012031198A2 Novel antigen binding proteins
03/08/2012WO2012031140A1 Adsorption of immunopotentiators to insoluble metal salts
03/08/2012WO2012031122A2 Methods and compositions for the diagnosis and treatment of cancer and autoimmune disorders
03/08/2012WO2012031099A2 Anti-cxcl13 antibodies and methods of using the same
03/08/2012WO2012031076A1 Recombinant trypanosoma cruzi cells useful as anti-cancer immune agents
03/08/2012WO2012031046A2 Lipids suitable for liposomal delivery of protein-coding rna
03/08/2012WO2012031043A1 Pegylated liposomes for delivery of immunogen-encoding rna
03/08/2012WO2012031027A1 Biomarkers and methods of treatment
03/08/2012WO2012030904A2 Human immunodeficiency virus (hiv)-neutralizing antibodies
03/08/2012WO2012030901A1 Small liposomes for delivery of immunogen-encoding rna
03/08/2012WO2012030720A1 Newcastle disease virus vectored herpesvirus vaccines
03/08/2012WO2012030394A1 Treatment of myocardial infarction using tgf - beta antagonists
03/08/2012WO2012029997A1 Influenza virus neutralizing antibody and method for screening same
03/08/2012WO2012029792A1 Compound having activity for inhibiting tgf-β receptor activation, method for screening same, and composition for prevention or treatment of hepatitis c virus-induced diseases
03/08/2012WO2012029023A1 Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
03/08/2012WO2012028741A1 Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof
03/08/2012WO2012028622A2 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same
03/08/2012WO2012028315A1 A stabilizer for the preparation of a dry polio injectable vaccine composition
03/08/2012WO2012027850A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012WO2012027821A1 A trkc receptor agonist antibody to treat neurodegenerative and motor neuron diseases
03/08/2012WO2012027814A1 Immunomodulation by means of a recombinant bacterial strain
03/08/2012WO2011160859A4 Antibody derivatives
03/08/2012WO2011146612A3 Latent human immunodeficiency virus reactivation
03/08/2012WO2011140550A3 Immunogen adherence and method of making and using same
03/08/2012WO2011138032A3 Universal influenza vaccines and methods for their generation
03/08/2012WO2011136911A3 Anti-erbb3 antibodies
03/08/2012WO2011133819A3 Methods of enhancing antibody-dependent cellular cytotoxicity
03/08/2012WO2011132955A3 Use of hades as tumor suppressor target
03/08/2012WO2011130434A3 Antibodies that bind human cd27 and uses thereof
03/08/2012WO2011130417A3 HUMAN FGF RECEPTOR AND β-KLOTHO BINDING PROTEINS
03/08/2012WO2011130249A3 Methods and compositions for inhibition of treg cells
03/08/2012WO2011122843A3 Combined inactivated vaccine for prevention of streptococcicosis of fish and method for preparing same
03/08/2012WO2011110531A3 Conjugation process of bacterial polysaccharides to carrier proteins
03/08/2012WO2011100489A3 Improved live bacterial vaccine safety
03/08/2012WO2011009042A8 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
03/08/2012WO2011008548A8 Vaccines and compositions against streptococcus pneumoniae
03/08/2012US20120059358 Dna vaccines encoding heat shock proteins
1 ... 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 ... 1823